BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19545527)

  • 1. Malaria antigen-mediated enhancement of interleukin-21 responses of peripheral blood mononuclear cells in African adults.
    Mewono L; Agnandji ST; Matondo Maya DW; Mouima AM; Iroungou BA; Issifou S; Kremsner PG
    Exp Parasitol; 2009 May; 122(1):37-40. PubMed ID: 19545527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.
    Luty AJ; Lell B; Schmidt-Ott R; Lehman LG; Luckner D; Greve B; Matousek P; Herbich K; Schmid D; Ulbert S; Migot-Nabias F; Dubois B; Deloron P; Kremsner PG
    Eur Cytokine Netw; 1998 Dec; 9(4):639-46. PubMed ID: 9889408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody and cellular immune responses to Plasmodium falciparum histidine-rich protein II in malaria-exposed individuals in Orissa, India.
    Das P; Grewal JS; Chauhan VS
    Trans R Soc Trop Med Hyg; 2010 May; 104(5):371-3. PubMed ID: 20116080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area.
    Moormann AM; John CC; Sumba PO; Tisch D; Embury P; Kazura JW
    Am J Trop Med Hyg; 2006 Apr; 74(4):585-90. PubMed ID: 16606988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
    Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
    Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
    Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
    Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on malaria vaccine].
    Dieye A; Launois P; Sarthou JL
    Dakar Med; 1990; 35(2):268-75. PubMed ID: 2135805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune responses to Plasmodium falciparum antigens in adult Gambians.
    Riley EM; Jepsen S; Andersson G; Otoo LN; Greenwood BM
    Clin Exp Immunol; 1988 Mar; 71(3):377-82. PubMed ID: 3133141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.
    Lyke KE; Burges RB; Cissoko Y; Sangare L; Kone A; Dao M; Diarra I; Fernández-Vina MA; Plowe CV; Doumbo OK; Sztein MB
    Infect Immun; 2005 Sep; 73(9):5799-808. PubMed ID: 16113298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.
    Flanagan KL; Mwangi T; Plebanski M; Odhiambo K; Ross A; Sheu E; Kortok M; Lowe B; Marsh K; Hill AV
    Am J Trop Med Hyg; 2003 Apr; 68(4):421-30. PubMed ID: 12875291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response.
    Bueno LL; Fujiwara RT; Soares IS; Braga EM
    Vaccine; 2008 Feb; 26(9):1204-13. PubMed ID: 18242795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malaria.
    Mewono L; Matondo Maya DW; Matsiegui PB; Agnandji ST; Kendjo E; Barondi F; Issifou S; Kremsner PG; Mavoungou E
    Eur Cytokine Netw; 2008 Mar; 19(1):30-6. PubMed ID: 18299268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas.
    Allsopp CE; Sanni LA; Reubsaet L; Ndungu F; Newbold C; Mwangi T; Marsh K; Langhorne J
    J Infect Dis; 2002 Mar; 185(6):812-9. PubMed ID: 11920299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
    Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children.
    D'Ombrain MC; Robinson LJ; Stanisic DI; Taraika J; Bernard N; Michon P; Mueller I; Schofield L
    Clin Infect Dis; 2008 Dec; 47(11):1380-7. PubMed ID: 18947328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of T-cell responses in malaria-exposed and non-exposed donors using Plasmodium falciparum asexual blood stages enriched by a simple centrifugation method.
    Farouk SE; Shen J; Tangteerawatana P; Bolad A; Berzins K; Troye-Blomberg M
    Acta Trop; 2006 Jan; 97(1):42-9. PubMed ID: 16280120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
    Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
    Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria.
    Dodoo D; Omer FM; Todd J; Akanmori BD; Koram KA; Riley EM
    J Infect Dis; 2002 Apr; 185(7):971-9. PubMed ID: 11920322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.